MOXO Diagnosis is the preferred decision support tool trusted by clinicians worldwide when it comes to diagnosing attentional difficulties.
As the industry leading continuous performance test (CPT), we make diagnosing ADHD convenient, easy, and precise.
How We Support Clinicians
Exceptional accuracy
The MOXO assessment has been rigorously tested by both clinicians and academics and boasts 91+% accuracy, and 85%+ sensitivity and specificity.
MOXO is the only assessment that both ensures validity and indicates attempts of malingering.
Ease of use
Easily manage your patients and review their assessment results.
Our modern, intuitive, cloud-based platform allows clinicians to send, run, observe and review assessments from anywhere.
Intervention monitoring
MOXO is an ideal measure of intervention effectiveness with over 20% of clients using it for intervention efficacy.
MOXO has demonstrated excellent test-retest reliability, maintaining consistency with a one-hour administration gap.
Adults (age 20 and above) accounted for 24% of all MOXO assessments conducted worldwide during 2023.
This amounts to a tri-fold increase compared to pre-covid usage.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy